A comparison of novel developed centrifugal-flow and conventional pulsatile-flow extracorporeal left ventricular assist devices in patients with cardiogenic shock : Sub-analysis of NCVC-BTD_01 trial

A comparison of novel developed centrifugal-flow and conventional pulsatile-flow extracorporeal left ventricular assist devices in patients with cardiogenic shock : Sub-analysis of NCVC-BTD_01 trial - A comparison of centrifugal- and pulsatile-flow extracorporeal LVAD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040456

Enrollment

Registered

2020-05-20

Start date

2020-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who were implanted with extracorporeal left ventricular assist device at the National Cerebral and Cardiovascular Center in Japan

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were implanted with extracorporeal left ventricular assist device at the National Cerebral and Cardiovascular Center in Japan

Exclusion criteria

Exclusion criteria: Subjects without informed consent

Design outcomes

Primary

Measure	Time frame
We assess the death and major cardiac events 60 days after ELVAD implantation.	—

Secondary

Measure	Time frame
We also assess the changes in organ dysfunction including liver and renal function and cardiac function early phase after E-LVAD implantation.	—

Countries

Japan

Contacts

Public ContactTakuya Watanabe

National Cerebral and Cardiovascular Center Department of transplant medicine

watanabe.takuya@ncvc.go.jp0661701069

Outcome results